At a three-day retreat in Ottawa this week, New Democrat members of Parliament are expected to focus discussions on getting more wins out of their confidence-and-supply agreement with the federal Liberals.
Kwan said pulling out of the agreement remains an option.
“We’re going to have to wait and see how things unfold. I mean, our agreement is very clear to say what are the items that the government needs to deliver on,” Kwan said.
She said that will include seeking to expand dental coverage to more Canadians and pushing for more investment in Indigenous housing.
The caucus is also eying bills it hopes will be brought forward this year, she said, after Parliament returns at the end of the month: a “just transition” bill for energy workers whose jobs could be affected by environmental policy, and a Canada Pharmacare Act committing the government to publicly fund prescription drugs.
“The pharmacare piece will require legislation. That’s part of the agreement, and so legislation will certainly come forward,” Kwan said.
The confidence-and-supply agreement stipulated that a pharmacare bill must be tabled by the end of 2023, and that a “National Drug Agency” would be tasked to “develop a national formulary of essential medicines and bulk purchasing plan by the end of the agreement.”
In 2020, the NDP’s House leader, Peter Julian, had proposed a private members’ bill outlining a universal pharmacare program. It was defeated in the House of Commons in February 2021, with the vast majority of Liberals, Conservatives and Bloc Québécois voting against.
Kwan is hopeful that such a bill will have more support a second time around.
“There is a framework we can build on,” she said, adding that the NDP’s health critic, Don Davies, is “working very hard.”